Dabrafenib Mesylate and Magnesium L-Aspartate Hydrochloride Powder Packets
Determining the interaction of Dabrafenib Mesylate and Magnesium L-Aspartate Hydrochloride Powder Packets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: dabrafenib
Brand name: Tafinlar
Synonyms: Dabrafenib
Generic Name: magnesium aspartate
Brand name: Maginex, Maginex DS
Synonyms: Magnesium L-Aspartate Hydrochloride Tablets, Magnesium L-aspartate Hydrochloride
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Dabrafenib Mesylate-Magnesium L-Aspartate Hydrochloride Tablets
- Dabrafenib Mesylate-Magnesium L-lactate
- Dabrafenib Mesylate-Magnesium lactate
- Dabrafenib Mesylate-Magnesium oxide
- Dabrafenib Mesylate-Magnesium Oxide 400
- Dabrafenib Mesylate-Magnesium salicylate
- Magnesium L-Aspartate Hydrochloride Powder Packets-Dacarbazine
- Magnesium L-Aspartate Hydrochloride Powder Packets-Dacarbazine Intravenous, Injection
- Magnesium L-Aspartate Hydrochloride Powder Packets-Daclatasvir
- Magnesium L-Aspartate Hydrochloride Powder Packets-Daclatasvir Dihydrochloride
- Magnesium L-Aspartate Hydrochloride Powder Packets-Daclizumab
- Magnesium L-Aspartate Hydrochloride Powder Packets-Daclizumab Subcutaneous